Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Ramps Up U.S. Sales Force Before Nexium, Statin Launches

Executive Summary

AstraZeneca plans to hire more in-house sales reps and decrease its "substantial reliance on contract sales organizations," Senior VP-Commercialization and Portfolio Management David Brennan said at the company's half-year results presentation in London Aug. 1.

You may also be interested in...



AstraZeneca Faslodex Is First Launch For Doubled Oncology Sales Force

AstraZeneca's Faslodex is the first launch to be detailed by the company's recently-expanded oncology sales force, following FDA approval of the estrogen receptor down-regulator April 25

AstraZeneca Faslodex Is First Launch For Doubled Oncology Sales Force

AstraZeneca's Faslodex is the first launch to be detailed by the company's recently-expanded oncology sales force, following FDA approval of the estrogen receptor down-regulator April 25

AstraZeneca Prilosec OTC Prevention Claim Up For Committee Review Oct. 20

AstraZeneca is seeking a prevention claim for an over-the-counter version of its proton pump inhibitor Prilosec (omeprazole).

Related Content

UsernamePublicRestriction

Register

PS036453

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel